نشر يوم 15. October 2020

Treatment of AIDS and other infections in Vivantes

On October 1, 2020, Dr. Caroline Isner took up her position as new Chief Physician in the Department of Internal Medicine - Infectiology at the Vivantes Auguste Viktoria Hospital (AVK). The treatment spectrum of the clinic will be expanded in view of the worldwide increasing antibiotic resistance and multi-resistant germs. The care for HIV / AIDS patients will remain in its entirety. 

Schöneberg Model and Interdisciplinary Care

Dr. Caroline Isner, Chief Physician in the Clinic for Internal Medicine - Infectiology at the Vivantes Auguste Viktoria Hospital: "HIV / AIDS with the Schöneberg Model will remain the focus of our clinic. Our patients should continue benefiting from this long-standing and extraordinary expertise and interdisciplinary cooperation at the AVK".  In order to get to know the outpatient sector better, the new head physician last worked in an HIV-focused practice in Berlin.

Dr. Caroline Isner is French and grew up in Frankfurt am Main. After studying medicine in Ulm, she worked for two years at Klinikum Nord in Hamburg before completing her specialist training in internal medicine at Albert Einstein College in the Bronx, New York and later her advanced training in infectiology at UCLA (University of California, Los Angeles). From 2013 to 2019 she was a senior physician in the Medical Clinic for Infectiology at the Charité, where she also established and managed the Antibiotic Stewardship Program.

Greater patient safety: reducing multiresistance with antibiotic stewardship

Infectiology is facing increasing challenges, not least due to the use of implants, transplants and immunosuppressive therapies, explains Dr. Caroline Isner. In addition to the development of innovative and individualized therapeutic approaches, another focus will be the further development of an antibiotic stewardship (ABS) at Vivantes.

Dr. Isner: "The programmatic use of rational anti-infective therapy, i.e. the cautious application of antibiotics, will reduce multi-resistance in the long term. This will improve the quality of treatment and patient safety and reduce hospitalization times. But only together will we have a chance against multi-resistant pathogens."

She will therefore bundle the existing projects around ABS and promote cooperation between all parties involved.

بيان صحفي
Science & Education: Corona
Read article
بيان صحفي
Treatment of AIDS and other infections in Vivantes
Read article
بيان صحفي
Infectious diseases - a new one every year
Infectious diseases are the most common cause of death worldwide. Every year, a new one is added to the existing ones.
Read article